Trial Profile
A phase 1b study of ASN 004 in patients with breast cancer
Status:
Planning
Phase of Trial:
Phase I
Latest Information Update: 05 Nov 2015
Price :
$35
*
At a glance
- Drugs ASN 004 (Primary)
- Indications Breast cancer
- Focus Adverse reactions
- 05 Nov 2015 New trial record